Targeting hedgehog in cancer stem cells: How a paradigm shift can improve treatment response

Future Oncology

Volumn 3, Issue 5, 2007, Pages 569-574

  Tung, David C Y ^a   Chao, K S Clifford ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Cancer stem cell; Multiple drug resistance; Sonic hedgehog pathway

Indexed keywords

CYCLOPAMINE; DOCETAXEL; ETOPOSIDE; METHOTREXATE; SONIC HEDGEHOG PROTEIN;

BASAL CELL CARCINOMA; CANCER GROWTH; CANCER RESISTANCE; CANCER STEM CELL; CANCER THERAPY; CARCINOGENESIS; CLONOGENESIS; DRUG DESIGN; DRUG TARGETING; EMBRYO DEVELOPMENT; GENE MUTATION; HUMAN; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; THEORY; TISSUE DIFFERENTIATION; TISSUE GROWTH; TREATMENT RESPONSE;

ANIMALS; DRUG RESISTANCE, MULTIPLE; HEDGEHOG PROTEINS; HUMANS; NEOPLASMS; NEOPLASTIC STEM CELLS; SIGNAL TRANSDUCTION;

EID: 35349026014     PISSN: 14796694     EISSN: 17448301     Source Type: Journal    
DOI: 10.2217/14796694.3.5.569     Document Type: Review

References (53)

1. Pasca di Magliano M, Hebrok M: Hedgehog signalling in cancer formation and maintenance. Nat. Rev. Cancer 3, 903-911 (2003).
2. Villavicencio EH, Walterhouse DO, Iannaccone PM: The sonic hedgehog-patched-gli pathway in human development and disease. Am. J. Hum. Genet. 67, 1047-1054 (2000).
3. Evangelista M, Tian H, de Sauvage FJ: The hedgehog signaling pathway in cancer. Am. J. Hum. Genet. 12, 5924-5928 (2006).
4. Ruiz I Altaba A, Sanchez P, Dahmane N: Gli and hedgehog in cancer: tumours, embryos and stem cells. Nat. Rev. Cancer 2, 361-372 (2002).
5. Taipale J, Beachy PA: The Hedgehog and Wnt signalling pathways in cancer. Nature 411, 349-354 (1001).
6. Wiliams JA, Guicherit OM, Zaharian BI et al.: Identification of a small molecule inhibitor of the hedgehog signaling pathway effects on basal cell carcinoma-like lesions. Proc. Natl Acad Sci. USA 100, 4616-4621 (2003).
7. Williams JA: Hedgehog signaling pathway as a target for therapeutic intervention in basal cell carcinoma. Drug News Perspect. 16, 657-662 (2003).
8. Agathodeous M, Locker M, Harris WA, Perron M: A general role of hedgehog in the regulation of proliferation. Cell Cycle 6, 156-159 (2007).
9. Ingham PW: Transducing Hedgehog: the story so far. EMBO J. 17, 3505-3511 (1998).
10. Ingham PW, McMahon AP: Hedgehog signaling in animal development: paradigms and principles. Genes Dev. 15, 3059-3087 (2001).
11. Fan H, Khavari PA: Sonic hedgehog opposes epithelial cell cycle arrest. J. Cell Biol. 147, 71-76 (1999).
12. Duman-Scheel M, Weng L, Xin S, Du W: Hedgehog regulates cell growth and proliferation by inducing cyclin D and cyclin E. Nature 417, 299-304 (2002).
13. Mill P, Mo R, Fu H et al. Sonic hedgehog-dependent activation of Gli2 is essential for embryonic hair follicle development. Genes Dev. 17, 282-294 (2003).
14. Karhadkar SS, Bova GS, Abdallah N et al. Hedgehog signalling in prostate regeneration, neoplasia and metastasis. Nature 431, 707-712 (2004).
15. Barnes EA, Kong M, Ollendorff V, Donoghue DJ: Patched1 interacts with cyclin B1 to regulate cell cycle progression. EMBO J. 20, 2214-2223 (2001).
16. Hahn H, Wicking C, Zaphiropoulous PG et al. Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome. Cell 85, 841-851 (1996).
17. Johnson RL, Rothman AL, Xie J et al. Human homolog of patched, a candidate gene for the basal cell nevus syndrome. Science 272, 1668-1671 (1996).
18. Oro AE, Higgins KM, Hu Z et al. Basal cell carcinomas in mice overexpressing sonic hedgehog. Science 276, 817-821 (1997).
19. Nilsson M, Undén AB, Krause D et al. Induction of basal cell carcinomas and trichoepitheliomas in mice overexpressing GLI-1. Proc. Natl. Acad. Sci. USA 97, 3438-3443 (2000).
20. Grachtchouk M, Mo R, Yu S et al. Basal cell carcinomas in mice overexpressing Gli2 in skin. Nat. Genet. 24, 216-217 (2000).
21. Bale AE, Yu KP: The hedgehog pathway and basal cell carcinomas. Hum. Mol. Genet. 10, 757-762 (2001).
22. Berman DM, Karhadkar SS, Hallahan AR et al. Medulloblastoma growth inhibition by hedgehog pathway blockade. Science 297, 1559-1561 (2002).
23. Taipale J, Chen JK, Cooper MK et al. Effects of oncogenic mutations in Smoothened and Patched can be reversed by cyclopamine. Nature 406, 1005-1009 (2000).
24. Chen JK, Taipale J, Young KE, Maiti T, Beachy PA: Small molecule modulation of Smoothened activity. Proc. Natl. Acad. Sci. USA 99, 14071-14076 (2002).
25. Kiselyow AS: Targeting the hedgehog signaling pathway with small molecules. Anticancer Agents Med. Chem. 6, 445-459 (2006).
26. Romer J, Curran T: Targeting medulloblastoma: small-molecule inhibitors of the Sonic Hedgehog pathway as potential cancer therapeutics. Cancer Res. 65, 4975-4978 (2005).
27. Rubin LL, de Sauvage FJ: Targeting the Hedgehog pathway cancer. Nat. Rev. Drug Discov. 5, 1026-1033 (2006).
28. Watkins DN, Berman DM, Burkholder SG et al. Hedgehog signalling within airway epithelial progenitors and in small-cell lung cancer. Nature 422, 313-317 (2003).
29. Fan L, Pepicelli CV, Dibble CC et al. Hedgehog signaling promotes prostate xenograft tumor growth. Endocrinology 145, 3961-3970 (2004).
30. Sanchez P, Hernández AM, Stecca B et al. Inhibition of prostate cancer proliferation by interference with sonic hedgehog-GLI1 signaling. Proc. Natl Acad Sci. USA 101, 12561-12566 (2004).
31. Thayer SP, di Magliano MP, Heiser PW et al. Hedgehog is an early and law mediator of pancreatic cancer tumorigenesis. Nature 425, 851-856 (2003).
32. Berman DM, Karhadkar SS, Maitra A et al. Widespread requirement for hedgehog ligand stimulation in growth of digestive tract tumours. Nature 425, 846-851 (2003).
33. Harmon EB, Ko AH, Kim SK: Hedgehog signaling in gastrointestinal development and disease. Curr. Mol. Med. 2, 67-82 (2002).
34. Sims-Mourtada J, Izzo JG, Apisarnthanarax S et al. Hedgehog: an attribute to tumor regrowth after chemoradiotherapy and a target to improve radiation response. Am. J. Hum. Genet. 12, 6565-6572 (2006).
35. Coia LR, Minsky BD, Berkey BA et al. Outcome of patients receiving radiation for cancer of the esophagus: results of the 1992-1994 Patterns of Care Study. J. Clin. Oncol. 18, 455-462 (2000).
36. el-Serag HB: The epidemic of esophageal adenocarcinoma. Gastroenterol. Clin. North Am. 31, 421-440 (2002).
37. Kubo A, Corley DA. Marked regional variation in adenocarcinomas of the esophagus and the gastric cardia in the United States. Cancer 95, 2096-2102 (2002).
38. Kuhn A, Corley DA: Marked multi-ethnic variation of esophageal and gastric cardia carcinomas within the United States. Am. J. Gastroenterol. 99, 582-588 (2004).
39. Iyer R, Wilkinson N, Demmy T, Javle M: Controversies in the multimodality management of locally advanced esophageal cancer: evidence-based review of surgery alone and combined-modality therapy. Ann. Surg. Oncol. 11, 665-673 (2004).
40. Kleinberg L, Gibson MY, Forastiere AA: Chemoradiotherapy for localized esophageal cancer: regimen selection and molecular mechanisms of radiosensitization. Nat. Clin. Pract. Oncol. 4, 282-294 (2007).
41. Urba S: Esophageal cancer: preoperative or definitive chemoradiation. Ann. Oncol. 15 (Suppl. 4), iv93-iv96 (2004).
42. Wechsler-Reya R, Scott MP: The developmental biology of brain tumors. Annu. Rev. Neurosci. 24, 385-428 (2001).
43. Wicha MS, Liu S, Dontu G: Cancer stem cells: an old idea - a paradigm shift. Cancer Res. 66, 1883-1890; discussion 1895-1896 (2006).
44. Dean M: Cancer stem cells: redefining the paradigm of cancer treatment strategies. Mol. Interv. 6, 140-148 (2006).
45. Al-Hajj M, Clarke MF: Self-renewal and solid tumor stem cells. Oncogene 23, 7274-7282 (2004).
46. Beachy PA, Karhadkar SS, Berman DM: Tissue repair and stem cell renewal in carcinogenesis. Nature 432, 324-331 (2004).
47. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF: Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad Sci. USA 100, 3983-3988 (2003).
48. Hemmati HD, Nakano I, Lazareff JA et al.: Cancerous stem cells can arise from pediatric brain tumors. Proc. Natl Acad Sci. USA 100, 15178-15183 (2003).
49. Liu S, Dontu G, Wicha MS: Mammary stem cells, self-renewal pathways, and carcinogenesis. Breast Cancer Res. 7, 86-95 (2005).
50. Gottesman MM, Fojo T, Bates SE: Multidrug resistance in cancer: role of ATP-dependent transporters. Nat. Rev. Cancer 2, 48-58 (2002).
51. Xia F, Powell SN: The molecular basis of radiosensitivity and chemosensitivity in the treatment of breast cancer. Semin. Radiat. Oncol. 12, 296-304 (2002).
52. Sims-Mourtada J, Izzo JG, Ajani J, Chao KS: Sonic Hedgehog promotes multiple drug resistance by regulation of drug transport. Oncogene 26, 5674-5679 (2007).
53. Szakacs G, Paterson JK, Ludwig JA, Booth-Genthe C, Gottesman MM: Targeting multidrug resistance in cancer. Nat. Rev. Drug Discov. 5, 219-234 (2006).